Compare EXAS & CPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXAS | CPB |
|---|---|---|
| Founded | 1995 | 1869 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0B | 9.4B |
| IPO Year | N/A | N/A |
| Metric | EXAS | CPB |
|---|---|---|
| Price | $101.58 | $28.83 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 20 | 16 |
| Target Price | ★ $77.94 | $32.38 |
| AVG Volume (30 Days) | ★ 10.8M | 7.1M |
| Earning Date | 11-03-2025 | 12-09-2025 |
| Dividend Yield | N/A | ★ 5.43% |
| EPS Growth | N/A | ★ 5.83 |
| EPS | N/A | ★ 1.94 |
| Revenue | $3,082,033,000.00 | ★ $10,158,000,000.00 |
| Revenue This Year | $19.40 | N/A |
| Revenue Next Year | $13.51 | $1.11 |
| P/E Ratio | ★ N/A | $14.82 |
| Revenue Growth | ★ 14.47 | 2.71 |
| 52 Week Low | $38.81 | $27.85 |
| 52 Week High | $101.95 | $43.85 |
| Indicator | EXAS | CPB |
|---|---|---|
| Relative Strength Index (RSI) | 89.65 | 38.82 |
| Support Level | $100.95 | $27.85 |
| Resistance Level | $101.95 | $29.11 |
| Average True Range (ATR) | 0.35 | 0.83 |
| MACD | -0.87 | -0.19 |
| Stochastic Oscillator | 61.17 | 23.88 |
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
Over the past 150-plus years, Campbell's has evolved into a leading domestic packaged food manufacturer, with a portfolio that extends beyond its iconic red-and-white labeled canned soup. In fiscal 2025 (July year-end), snacks accounted for 43% of its revenue, followed by soup (27%), other simple meals (23%), and beverages (7%). Outside its namesake, its brands include Pepperidge Farm, Goldfish, Snyder's of Hanover, Swanson, Pacific Foods, Prego, Pace, V8, and recently acquired Rao's (a deal that closed in 2024). Around 90% of its revenue results from the US and the remainder from Canada and Latin America.